Skip to content

Stylistic Memory Enhancement

Stylistic Memory Enhancement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03206034
Acronym
SME
Enrollment
20
Registered
2017-07-02
Start date
2013-03-01
Completion date
2015-12-31
Last updated
2017-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Memory, Cognition

Brief summary

Impairments in higher level cognitive processing, such as new learning and memory, are common in Multiple Sclerosis (MS) and negatively impact multiple aspects of everyday life, including occupational and social functioning. Despite this, few studies have attempted to remediate these cognitive deficits in order to improve everyday functioning. While not applied in traditional rehabilitation protocols as of yet, many techniques from cognitive psychology significantly improve learning and memory in healthy persons. These techniques include the generation effect (GE), the spacing effect (SE), and the testing effect (TE). These techniques have recently been incorporated into an 8-session treatment protocol, Stylistic Memory Enhancement (SME), designed to teach participants about each of the techniques, train them on how to apply the techniques in daily life and practice their application to daily life memory demanding situations. The protocol includes teaching participants how to restructure a memory demanding situation in order to make optimal use of self-generation, spaced learning and self-testing. The objective of the study is to test the efficacy of the SME in an MS population.

Interventions

BEHAVIORALStylistic Memory Enhancement

Sponsors

Kessler Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Double blind placebo controlled randomized control trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

Clinically definite MS between the ages of 18 and 59. Participants must have impairment in new learning (determined by an in-person screen) with intact language comprehension.

Exclusion criteria

* History of alcohol or drug abuse/dependence, * Major psychiatric disturbance (e.g. bipolar disorder, schizophrenia) and neurological history other than MS. * Corticosteroid use within the last month prior to the participation. * Less than 1 month post most recent exacerbation.

Design outcomes

Primary

MeasureTime frameDescription
California Verbal Learning Test (CVLT-II- Total learningBaseline and post-intervention (5 weeks between testing sessions)Measure of change in new learning

Secondary

MeasureTime frameDescription
Memory Functioning QuestionnaireBaseline and post-intervention ( 5 weeks between testing sessions)Measure of change in Self-report of everyday memory functioning

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026